StockData
Humacyte, Inc. logo

Humacyte, Inc. (HUMA) stock

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.50−0.04 (-7.27%)

Close on Nov 17, 2026Market cap $139.18MP/E –Yield –

Humacyte pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Humacyte's pe ratio was 7.9× on Jan 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20237.9×+1.6
2022Dec 30, 20226.3×–

More Humacyte figures

See a number that looks wrong?